The problem
What today's M2M auth can't deliver in pharma.
Pharmaceutical cold-chain logistics traverses a chain of independent handlers — manufacturer, freight forwarder, customs, distributor, hospital pharmacy — across multiple regulatory regimes and connectivity environments. Existing serialisation schemes (DSCSA, FMD) authenticate the product but do not authenticate handler-to-handler custody transfer cryptographically. The chain depends on the integrity of every party and the central authority each subscribes to.
How EdSSA addresses it
What EdSSA does differently here.
EdSSA Nano provides authenticated handler-to-handler custody transfer that does not require a shared central authority. Each handler authenticates the next via a stateless protocol that survives multi-day transit, transcontinental flight, and offline customs hold. The cryptographic chain is post-quantum and sovereign-clean — fit for the regulatory environment that pharma is moving into.
Use cases
Concrete operational scenarios.
- Manufacturer-to-distributor custody handoff with cryptographic continuity
- Cold-chain breach detection coupled to authenticated sensor data
- Serialised unit authentication along DSCSA / FMD pathways
- Cross-border pharmaceutical logistics with sovereignty-clean authentication
Compliance & standards
Standards and regulatory regimes.
US DSCSA. EU FMD. EU GDP guidelines. WHO PQS. ISO 9001 / ISO 14001 alignment. GDPR-clean.
Audit emission
Audit-grade event logging with configurable tiers from compliance baseline to incident-response trace. DSCSA and FMD event records emitted per verified handoff; optional Merkle-anchored tamper-evidence for evidence-grade audit trails.
Customers
Operators in this vertical.
“Cryptographic custody from manufacturer to pharmacy. The chain holds across borders, carriers, and customs.”